OXFORD NANOPORE TECHNOLOGIES PLC Financials Oxford Nanopore Technologies plc
Equities
ONT
GB00BP6S8Z30
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.6 GBX | +1.33% |
|
-3.45% | -48.85% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,726 | 2,034 | 1,788 | 907.4 | - | - |
| Enterprise Value (EV) 1 | 5,263 | 1,712 | 1,560 | 631 | 735.8 | 828.8 |
| P/E ratio | -30.3 x | -22.4 x | -11 x | -6.16 x | -7.1 x | -8.33 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 42.8 x | 10.2 x | 10.5 x | 4.82 x | 3.75 x | 2.94 x |
| EV / Revenue | 39.4 x | 8.62 x | 9.19 x | 3.35 x | 3.04 x | 2.69 x |
| EV / EBITDA | -91.2 x | -21.8 x | -14.9 x | -6.04 x | -9.41 x | -17.9 x |
| EV / FCF | -69.8 x | -18.7 x | -9.59 x | -4.93 x | -6.71 x | -8.75 x |
| FCF Yield | -1.43% | -5.35% | -10.4% | -20.3% | -14.9% | -11.4% |
| Price to Book | 8.15 x | 2.93 x | 2.7 x | 1.77 x | 2.36 x | 3.01 x |
| Nbr of stocks (in thousands) | 820,404 | 825,255 | 858,887 | 862,585 | - | - |
| Reference price 2 | 6.980 | 2.465 | 2.082 | 1.052 | 1.052 | 1.052 |
| Announcement Date | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 133.7 | 198.6 | 169.7 | 188.3 | 241.8 | 308.3 |
| EBITDA 1 | - | -57.7 | -78.63 | -104.9 | -104.4 | -78.21 | -46.33 |
| EBIT 1 | - | -82.9 | -110.5 | -146.6 | -146.9 | -124.5 | -95.62 |
| Operating Margin | - | -62.02% | -55.64% | -86.38% | -78.01% | -51.5% | -31.02% |
| Earnings before Tax (EBT) 1 | - | -166 | -83.41 | -149.8 | -146.8 | -119.6 | -103.2 |
| Net income 1 | -61.24 | -167.6 | -91.02 | -154.5 | -149.9 | -133.3 | -106.2 |
| Net margin | - | -125.4% | -45.83% | -91.06% | -79.62% | -55.14% | -34.46% |
| EPS 2 | -1.990 | -0.2300 | -0.1100 | -0.1900 | -0.1708 | -0.1482 | -0.1263 |
| Free Cash Flow 1 | - | -75.36 | -91.62 | -162.7 | -128.1 | -109.7 | -94.77 |
| FCF margin | - | -56.38% | -46.13% | -95.91% | -68.03% | -45.35% | -30.74% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 8/2/21 | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 74.71 | 122.3 | 76.26 | 86 | 83.67 | 90 | 104 | 114 | 132 | 145 |
| EBITDA 1 | -25.86 | -34.61 | -44.02 | -39.37 | -65.56 | -28 | -26 | -19 | -17 | -11 |
| EBIT 1 | -39.33 | -22.96 | -59.76 | -74.78 | -87.32 | -52 | -46 | -48 | -41 | -46 |
| Operating Margin | -52.64% | -18.77% | -78.37% | -86.96% | -104.37% | -57.78% | -44.23% | -42.11% | -31.06% | -31.72% |
| Earnings before Tax (EBT) 1 | -121.6 | -27.63 | -55.78 | -66.56 | -83.21 | -51 | -46 | -48 | -41 | - |
| Net income 1 | -122.8 | -30.18 | -60.85 | -70.1 | -13.11 | -54 | -49 | -51 | -44 | -49 |
| Net margin | -164.35% | -24.66% | -79.8% | -81.51% | -15.67% | -60% | -47.12% | -44.74% | -33.33% | -33.79% |
| EPS 2 | -0.1100 | -0.0400 | -0.0700 | -0.0800 | -0.1100 | -0.0600 | -0.0600 | -0.0600 | -0.0500 | -0.0600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/22/22 | 9/13/22 | 3/21/23 | 9/6/23 | 3/6/24 | - | - | - | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 463 | 323 | 228 | 276 | 172 | 78.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -75.4 | -91.6 | -163 | -128 | -110 | -94.8 |
| ROE (net income / shareholders' equity) | - | -19% | -13% | -23.1% | -25.3% | -30.4% | -43.7% |
| ROA (Net income/ Total Assets) | - | -15.1% | -10.9% | -19.3% | -22.9% | -25.6% | -25.6% |
| Assets 1 | - | 1,111 | 832.9 | 800.5 | 655.9 | 520.1 | 415.2 |
| Book Value Per Share 2 | - | 0.8600 | 0.8400 | 0.7700 | 0.5900 | 0.4500 | 0.3500 |
| Cash Flow per Share 2 | - | -0.0700 | -0.0600 | -0.1600 | -0.1200 | -0.0800 | -0.0700 |
| Capex 1 | - | 21.5 | 42.2 | 25.4 | 35.6 | 36.2 | 40 |
| Capex / Sales | - | 16.11% | 21.27% | 14.99% | 18.93% | 14.96% | 12.97% |
| Announcement Date | 8/2/21 | 3/22/22 | 3/21/23 | 3/6/24 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1.052
GBP
Average target price
1.98
GBP
Spread / Average Target
+88.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -48.85% | 1.16B | |
| +6.02% | 215B | |
| +9.25% | 187B | |
| +19.58% | 143B | |
| +29.74% | 110B | |
| +1.60% | 64.68B | |
| +15.27% | 52.96B | |
| +2.69% | 49.84B | |
| -5.47% | 38.32B | |
| +1.58% | 35.86B |
- Stock Market
- Equities
- ONT Stock
- Financials Oxford Nanopore Technologies plc
